Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Presentation TCT 2025

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Presenter: Rui Wang

October 28, 2025

Presentation TCT 2025

Perspective 1: IABP: Not Dead Yet

Presenter: Guy Witberg

October 28, 2025

Presentation TCT 2025

TCT 282: Clinical Characteristics and Outcome in IABP-Supported Cardiogenic Shock Among Patients Transferred to Tertiary Care Centers

Presenter: Jonas Sundermeyer

October 27, 2025

Presentation TCT 2025

TCT 968: Impella vs. IABP in High-Risk PCI Without Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Outcomes

Presenter: AHMED K. ABDELRAHMAN

October 27, 2025

Presentation TCT 2025

TCT 971: Analysis of Impella and IABP Supported Elective HR-PCI Outcomes and EF Recovery in a Large U.S. Based Electronic Medical Record Database

Presenter: Jason Wollmuth

October 27, 2025

Presentation TCT 2025

Case-in-the-Box Presentation 2: Complex PCI in Cardiogenic Shock ACS with IABP, Haukeland University Hospital, Bergen, Norway

Presenter: Anja Oksnes

October 26, 2025

Presentation TCT 2025

TCT 247: A Systematic Review and Meta-Analysis of Impella Versus IABP in Myocardial Infarction-Related Cardiogenic Shock Revealed Significantly Higher Mortality With the Use of Impella

Presenter: Mohammad Reza Movahed

October 26, 2025

Presentation THT 2025

Catastrophic Migration of an Axillary IABP Salvaged With Endovascular Repair

Presenter: Swagata Patnaik

February 11, 2025

Presentation TCT 2024

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

Presenter: Arthur Garan

October 29, 2024

Presentation TCT 2024

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

Presenter: Wittawat Wattanasiriporn

October 28, 2024

Presentation TCT 2024

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

Presenter: Amin Polzin

October 28, 2024

Presentation NY Valves 2024

IABP Turmoil: Intra-Aortic Balloon Pump Induced Systolic Anterior Motion of the Mitral Valve and Dynamic Left Ventricular Outflow Tract Obstruction Leading to Ventricular Fibrillation After Failed Percutaneous Coronary Intervention of the Right Coronary…

Presenter: Dilesha Dilangi Kumanayaka

June 07, 2024

Presentation TCT 2023

Coronary Keynote Lecture: When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Presenter: Koji Takeda

October 24, 2023

Presentation THT 2023

Predictors of Longitudinal Change in Cardiac Index during Intra-Aortic Balloon Pump (IABP) Support

Presenter: Francesco Castagna

March 20, 2023

Presentation TCT 2022

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Presenter: Koji Takeda

September 19, 2022

Presentation THT 2022

The Role of IABP in the Management of Cardiogenic Shock

Presenter: Jennifer Cowger

February 02, 2022

Presentation TCT Abstracts Posters 2019

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

Presenter: Michael DiVita

October 09, 2019

Presentation

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Presenter: David Cox

April 11, 2019

Presentation SIF 2019

Why Impella (Not IABP) is always the default choice in MCS

Presenter: Morton J. Kern

March 29, 2019

Presentation JIM 2019

Interventional and Pharmacological Crossroads: our decision

Presenter: Marco Ferlini

February 15, 2019

Advertisement

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Perspective 1: IABP: Not Dead Yet

TCT 282: Clinical Characteristics and Outcome in IABP-Supported Cardiogenic Shock Among Patients Transferred to Tertiary Care Centers

TCT 968: Impella vs. IABP in High-Risk PCI Without Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Outcomes

TCT 971: Analysis of Impella and IABP Supported Elective HR-PCI Outcomes and EF Recovery in a Large U.S. Based Electronic Medical Record Database

Case-in-the-Box Presentation 2: Complex PCI in Cardiogenic Shock ACS with IABP, Haukeland University Hospital, Bergen, Norway

TCT 247: A Systematic Review and Meta-Analysis of Impella Versus IABP in Myocardial Infarction-Related Cardiogenic Shock Revealed Significantly Higher Mortality With the Use of Impella

Catastrophic Migration of an Axillary IABP Salvaged With Endovascular Repair

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

IABP Turmoil: Intra-Aortic Balloon Pump Induced Systolic Anterior Motion of the Mitral Valve and Dynamic Left Ventricular Outflow Tract Obstruction Leading to Ventricular Fibrillation After Failed Percutaneous Coronary Intervention of the Right Coronary…

Coronary Keynote Lecture: When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Predictors of Longitudinal Change in Cardiac Index during Intra-Aortic Balloon Pump (IABP) Support

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

The Role of IABP in the Management of Cardiogenic Shock

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

IMPELLA vs Intra-Aortic Balloon PumpA Reflective Perspective

Why Impella (Not IABP) is always the default choice in MCS

Interventional and Pharmacological Crossroads: our decision

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content